ARCHIVES

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

This article is from The Cancer Letter archive.

Vol. 03 No. 40 | October 7, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Accrual Picking Up, Still “Nothing To Write Home About;” Unfunded MDs ‘Subsidizing Entire Program”

June 3, 1988

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

James Watkins To Head AIDS Commission Following Mayberry’s Resignation

October 16, 1987

NCI Picks Duke To Lead caBIG’s Knowledge Center For Clinical Trials.

July 3, 2008